Silver Book Fact

Initiating and continuing beta-blocker use in most first-time heart attack survivors for 20 years would result in 72,000 fewer coronary heart disease deaths, 62,000 fewer heart attacks, and 447,000 gained life-years. Additionally, it would save up to $18 million.

Phillips, Kathryn A., Michael G. Shlipak, Pamela Coxson, Paul A. Heidenreich, Myriam G. Hunink, Paula A. Goldman, Lawrence W. Williams, Milton C. Weinstein, and Lee Goldman. Health and Economic Benefits of Increased Beta-Blocker Use Following Myocardial Infarction. JAMA. 2000; 284(21): 2748-54. http://jama.ama-assn.org/cgi/content/abstract/284/21/2748

Reference

Title
Health and Economic Benefits of Increased Beta-Blocker Use Following Myocardial Infarction
Publication
JAMA
Publication Date
2000
Authors
Phillips, Kathryn A., Michael G. Shlipak, Pamela Coxson, Paul A. Heidenreich, Myriam G. Hunink, Paula A. Goldman, Lawrence W. Williams, Milton C. Weinstein, and Lee Goldman
Volume & Issue
Volume 284, Issue 21
Pages
2748-54
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Satisfaction with HVD Treatment
    Among treated heart valve disease (HVD), 96% express “full satisfaction” and 78% are “very satisfied” with their treatment.  
  • A calculated approximate benefit-to-cost ratio for antihypertensive therapy is 10:1 for men and 6:1 for women.  
  • Antihypertensive therapy has been associated in clinical trials with a 1/3 reduction in stroke incidence, a 1/4 reduction in myocardical infarctions and a more than 1/2 reduction in heart failure.  
  • Through advances in risk-factor assessment, detection, and preventive strategies, the average age of acute myocardial infarction and heart failure patients has shifted around 10 to 15 years forward. One-year…  
  • Increased use of a blood-thinning drug prevents 40,000 strokes every year in the U.S.